Search - tctmd.com

Displaying 261 - 280 of 774

Sort: Relevancy | Date

Presentation NY Valves 2024

Hybrid Bailout TAVR to Treat LVOT Obstruction With Late Hemolysis Post Mitral Valve-in-Ring

Presenter: Tarun Chakravarty

June 06, 2024

Presentation NY Valves 2024

Redo Mitral TEER and AVP II Plug Implantation for Failed Acute Mitral TEER

Presenter: David Zemanek

June 06, 2024

Presentation NY Valves 2024

Mitral TEER Versus Redo-Surgery in Patients With Failed Mitral Valve Repair: A Single Center, Propensity Score-Matched Analysis

Presenter: Guido Ascione

June 06, 2024

Presentation NY Valves 2024

Impella-Assisted TAV in TAV in SAV for Acute Cardiogenic Shock

Presenter: Wally Omar

June 06, 2024

Presentation NY Valves 2024

Mitral Surgery After TEER

Presenter: Joanna Chikwe

June 06, 2024

Presentation NY Valves 2024

Can TAV-in-TAV Simulations be Useful in Procedural Planning?

Presenter: Vinod H. Thourani

June 06, 2024

Presentation NY Valves 2024

Simultaneous Transfemoral Aortic and Mitral Native Valve Replacement: A Step-by-Step Procedural Approach

Presenter: Jean-Michel Paradis

June 06, 2024

Presentation NY Valves 2024

Mitral Valve Repair: Optimal Annual Case Volume for Surgery

Presenter: Irbaz Hameed

June 06, 2024

Presentation NY Valves 2024

Crash and Burn TAVR - When ECMO Isn't Enough

Presenter: Spencer Ng

June 06, 2024

Presentation NY Valves 2024

Early vs Delayed Intervention for Aortic Stenosis: A Patient’s Perspective

Presenter: Megan Coylewright

June 06, 2024

Presentation NY Valves 2024

Case 2: TAVR in MAC With Lampoon and Sapien – Step-by-step Approach and Clinical Outcomes

Presenter: Adam B. Greenbaum

June 06, 2024

Presentation NY Valves 2024

How to Interpret the Pathology Data From TAVR Explants

Presenter: Stephanie Sellers

June 06, 2024

Presentation NY Valves 2024

Traumatic ASD Repair With Septal Occluder Followed by TEER

Presenter: Kamal Preet Singh

June 06, 2024

Presentation NY Valves 2024

Suitability of Mitral Annuloplasty Rings for a Valve-in-Ring Procedure With SAPIEN 3

Presenter: Syed Zaid

June 06, 2024

Presentation NY Valves 2024

An Every Day TAVI Gone Suicidal: How VA-ECMO Saved the Day

Presenter: Eduardo A. Arias

June 06, 2024

Presentation NY Valves 2024

Mitral Surgery After TAVR

Presenter: Percy Boateng

June 06, 2024

Presentation NY Valves 2024

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Presenter: Nicolas M. Van Mieghem

June 06, 2024

Presentation NY Valves 2024

Case 1: MAC Treated With Commercial TMVR (Tendyne) – Technical Considerations

Presenter: Jason H. Rogers

June 06, 2024

Presentation NY Valves 2024

The Future is Now! TAVR is a Favorable Alternative in AS Patients Under 65 Years Old

Presenter: Bernard Prendergast

June 06, 2024

Presentation NY Valves 2024

Use of VA ECMO for TAVR in a High Risk Patient After Cardiac Arrest

Presenter: Badri Aryal

June 06, 2024

Advertisement

Hybrid Bailout TAVR to Treat LVOT Obstruction With Late Hemolysis Post Mitral Valve-in-Ring

Redo Mitral TEER and AVP II Plug Implantation for Failed Acute Mitral TEER

Mitral TEER Versus Redo-Surgery in Patients With Failed Mitral Valve Repair: A Single Center, Propensity Score-Matched Analysis

Impella-Assisted TAV in TAV in SAV for Acute Cardiogenic Shock

Mitral Surgery After TEER

Can TAV-in-TAV Simulations be Useful in Procedural Planning?

Simultaneous Transfemoral Aortic and Mitral Native Valve Replacement: A Step-by-Step Procedural Approach

Mitral Valve Repair: Optimal Annual Case Volume for Surgery

Crash and Burn TAVR - When ECMO Isn't Enough

Early vs Delayed Intervention for Aortic Stenosis: A Patient’s Perspective

Case 2: TAVR in MAC With Lampoon and Sapien – Step-by-step Approach and Clinical Outcomes

How to Interpret the Pathology Data From TAVR Explants

Traumatic ASD Repair With Septal Occluder Followed by TEER

Suitability of Mitral Annuloplasty Rings for a Valve-in-Ring Procedure With SAPIEN 3

An Every Day TAVI Gone Suicidal: How VA-ECMO Saved the Day

Mitral Surgery After TAVR

Pre-emptive AVR for Moderate AS and Asymptomatic Severe AS: A Summary of Upcoming Trials

Case 1: MAC Treated With Commercial TMVR (Tendyne) – Technical Considerations

The Future is Now! TAVR is a Favorable Alternative in AS Patients Under 65 Years Old

Use of VA ECMO for TAVR in a High Risk Patient After Cardiac Arrest

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content